- Home
- ILPT vs NPCE Comparison
ILPT vs NPCE Comparison
Compare ILPT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- NPCE
- Stock Information
- Founded
- ILPT 2017
- NPCE 1997
- Country
- ILPT United States
- NPCE United States
- Employees
- ILPT N/A
- NPCE N/A
- Industry
- ILPT Real Estate Investment Trusts
- NPCE Medical Specialities
- Sector
- ILPT Real Estate
- NPCE Health Care
- Exchange
- ILPT Nasdaq
- NPCE Nasdaq
- Market Cap
- ILPT 366.2M
- NPCE 363.2M
- IPO Year
- ILPT 2018
- NPCE 2021
- Fundamental
- Price
- ILPT $5.28
- NPCE $9.94
- Analyst Decision
- ILPT
- NPCE Strong Buy
- Analyst Count
- ILPT 0
- NPCE 6
- Target Price
- ILPT N/A
- NPCE $16.67
- AVG Volume (30 Days)
- ILPT 264.0K
- NPCE 124.5K
- Earning Date
- ILPT 10-28-2025
- NPCE 11-04-2025
- Dividend Yield
- ILPT 3.79%
- NPCE N/A
- EPS Growth
- ILPT N/A
- NPCE N/A
- EPS
- ILPT N/A
- NPCE N/A
- Revenue
- ILPT $445,459,000.00
- NPCE $88,570,000.00
- Revenue This Year
- ILPT $3.44
- NPCE $22.13
- Revenue Next Year
- ILPT $1.78
- NPCE $6.07
- P/E Ratio
- ILPT N/A
- NPCE N/A
- Revenue Growth
- ILPT 1.08
- NPCE 23.32
- 52 Week Low
- ILPT $2.45
- NPCE $6.03
- 52 Week High
- ILPT $6.57
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- ILPT 38.46
- NPCE 42.64
- Support Level
- ILPT $4.92
- NPCE $10.42
- Resistance Level
- ILPT $6.08
- NPCE $10.81
- Average True Range (ATR)
- ILPT 0.22
- NPCE 0.45
- MACD
- ILPT -0.03
- NPCE -0.13
- Stochastic Oscillator
- ILPT 31.03
- NPCE 17.22
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.